NumerixS Investment Technologies’s Intersect ENT, Inc XENT Stock Holding History

NumerixS Investment Technologies’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,911	Closed	-$70K	–	1366
2020 Q1	$70K	Buy	+5,911	New	+$131K	0.04%	534
2019 Q3	–	Sell	-2,700	Closed	-$61K	–	1316
2019 Q2	$61K	Sell	2,700 -3,700	-58%	-$99.8K	0.02%	731
2019 Q1	$200K	Buy	6,400 +4,200	+191%	+$130K	0.03%	669
2018 Q4	$60K	Buy	2,200 +662	+43%	+$19.4K	0.02%	718
2018 Q3	$44K	Sell	1,538 -900	-37%	-$27K	0.01%	999
2018 Q2	$92K	Hold	2,438	–	–	0.02%	778
2018 Q1	$95K	Sell	2,438 -3,422	-58%	-$125K	0.02%	667
2017 Q4	$190K	Buy	5,860 +5,560	+1,853%	+$167K	0.04%	475
2017 Q3	$9K	Buy	+300	New	+$8.88K	﹤0.01%	1098
2016 Q3	–	Sell	-9,000	Closed	-$116K	–	1361
2016 Q2	$116K	Buy	+9,000	New	+$141K	0.02%	844

Other funds holding XENT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NumerixS Investment Technologies's XENT Position: Q2 2020 in Review

NumerixS Investment Technologies sold out of Intersect ENT, Inc (XENT) in Q2 2020, closing a stake of 5,911 shares — an estimated $70K sold.

NumerixS Investment Technologies first reported a position in XENT in Q2 2016 and held it in 10 quarters. The position peaked at $200K in Q1 2019. 108 funds tracked by Wall St. Rank hold XENT as of Q2 2020.

NumerixS Investment Technologies reported no remaining Intersect ENT, Inc position as of Q2 2020 after selling out during the quarter.
NumerixS Investment Technologies sold 5,911 Intersect ENT, Inc shares in Q2 2020, an estimated $70K.
NumerixS Investment Technologies first reported a position in Intersect ENT, Inc in Q2 2016 and held it in 10 quarters.
NumerixS Investment Technologies's Intersect ENT, Inc position peaked at $200K in Q1 2019.
108 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2020.

Based on NumerixS Investment Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.